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Vascular calcification is a major risk factor of cardiovascular
mortality, particularly for patients with end-stage renal
disease and diabetes. Although chronic inflammation is one
of the etiologic factors, the underlying mechanism is not fully
understood. To clarify this, we studied how nuclear factor-
kappa B (NF-jB) induction, a mediator of inflammation,
might promote vascular calcification. Activation of NF-jB by
tumor necrosis factor (TNF) promoted inorganic phosphate-
induced calcification in human aortic smooth muscle cells.
Pyrophosphate (an inhibitor of calcification) efflux to the
extracellular matrix was suppressed along with the decreased
expression of ankylosis protein homolog (ANKH), a
transmembrane protein that controls pyrophosphate efflux
of cells. The restoration of ANKH expression in these cells
overcame the decreased pyrophosphate efflux and
calcification. Tristetraprolin, a downstream product of NF-jB
activation, may mediate destabilization of ANKH mRNA as
its knockdown by shRNA increased ANKH expression and
decreased calcification. Furthermore, a rat chronic renal
failure model, with increased serum TNF levels, activated NF-
jB and decreased ANKH levels. In contrast, the inhibition of
NF-jB maintained ANKH expression and attenuated
vascular calcification both in vivo and in vitro. Both human
calcified atherosclerotic lesions and arteries from patients
with chronic kidney disease had activated NF-jB and
decreased ANKH expression. Thus, TNF-activated NF-jB
promotes inflammation-accelerated vascular calcification
by inhibiting ankylosis protein homolog expression and
consequent pyrophosphate secretion.
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Vascular calcification is a major risk factor of cardiovascular
mortality, particularly for patients with end-stage renal
disease,1–4 advanced atherosclerosis, and diabetes.5 Ap-
proaches to prevent and/or reverse macrovascular calcifica-
tion are far from ideal, partly because the mechanism is
heterogeneous and complex. Growing evidence suggests that
disturbed inorganic phosphate (Pi)/calcium metabolism,
osteogenic transition of vascular smooth muscle cells
(SMCs), and SMC apoptosis are associated with vascular
calcification. However, the underlying mechanisms control-
ling vascular calcification are still unclear.
Increased levels of serum inorganic Pi and chronic
inflammation during chronic renal failure (CRF) induce
vascular calcification. We and others found that chronic
inflammation and oxidative stress have a critical role in
vascular calcification. Al-Aly et al.6 reported that tumor
necrosis factor (TNF) induced Msh homeobox 2 (Msx2)
expression and activated Wnt signaling to promote arterial
calcification in an animal model of Type 2 diabetes.
Treatment with the TNF-a–neutralizing antibody infliximab
significantly abrogated aortic Msx2/Wnt signaling and
attenuated aortic calcium accumulation.6 Byon et al.7 found
that the osteochondrocytic transcription factor Runx2 was
activated by hydrogen peroxide and supported matrix
mineralization in cultured vascular SMCs. Recently, we
showed that high Pi level induced the production of
mitochondrial reactive oxygen species and activated NF-kB
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to induce vascular calcification in a rat CRF model.8
However, how nuclear factor-kappa B (NF-kB) activation
promotes vascular calcification is largely unknown.
The transcription factor NF-kB has an important role in
inflammation and immune responses. In most unstimulated
conditions, NF-kB is retained in the cytoplasm by inhibitor
of kappa B proteins (IkBs). NF-kB consists of homodimeric
and heterodimeric complexes of the Rel family proteins,
including p50, p52, p65/RelA, c-Rel, and RelB. In mamma-
lian cells, classical NF-kB is a heterodimer of p50 and p65/
RelA proteins, in which the p65/RelA subunit has transacti-
vation activity.9,10 NF-kB activation is associated with the
pathogenesis of chronic kidney disease (CKD), atherosclero-
sis, and diabetes.
Because TNF is one of the most potent activators of NF-
kB, we examined whether TNF promotes vascular calcifica-
tion by activating NF-kB in human aortic SMCs (HASMCs).
TNF-induced NF-kB potently enhanced Pi-induced miner-
alization in HASMCs. Unexpectedly, in addition to inducing
pro-osteogenic genes, TNF activation of NF-kB suppressed
the expression of progressive ankylosis protein homolog
(ANKH), an endogenous inhibitor of calcification, in
HASMCs. Moreover, NF-kB activation downregulated
ANKH in a rat CRF model. Inhibition of NF-kB activation
maintained ANKH expression and attenuated vascular
calcification in the CRF model. Our results suggest that
NF-kB has a critical role in chronic inflammation accelerat-
ing vascular calcification by inhibiting ANKH expression.
Targeting NF-kB may help prevent vascular calcification.
RESULTS
TNF accelerates Pi-induced calcification and regulates
osteogenic gene expression
Low-grade systemic chronic inflammation11 is a common
feature of end-stage renal disease, diabetes, and athero-
sclerosis.12 Pro-inflammatory cytokines such as TNF enhance
mineralization in mouse and bovine SMCs.13 To explore how
chronic inflammation affects vascular calcification, we
examined whether TNF could promote Pi-induced calcium
deposition in HASMCs. As shown in Figure 1a, TNF alone
did not induce calcification in HASMCs, but it significantly
potentiated Pi-induced calcium deposition as compared with
Pi alone, and this effect was TNF concentration dependent
(Figure 1b). Furthermore, the minimum concentration of Pi
needed to induce calcification was lower (from 2.6 to
2.0mmol/l) in the presence of TNF (Figure 1c). Next, we
used quantitative reverse transcription-PCR to analyze the
mRNA levels of key mediators associated with osteogenic
programming during calcification at 2, 8, and 72 h. Consis-
tent with previous findings,6,14 the expression of the pro-
osteogenic genes bone morphogenetic protein 2 (BMP2) and
Msx2 was induced with TNF added to Pi (Figure 1d and e).
Because vascular calcification can be modulated by both
positive and negative mechanisms, we also examined the
expression of calcification inhibitors. The addition of TNF
did not affect osteopontin expression with Pi induction
(Figure 1f) but significantly inhibited matrix Gla protein
(MGP) expression only at 72 h (Figure 1g). It is noteworthy
that the expression of ANKH began to decrease at 2 h and was
further reduced at 8 and 72h with TNF added (Figure 1h).
Decreased secretion of pyrophosphate (PPi) by ANKH
mediates the pro-calcification effect of TNF
ANKH is a multipass transmembrane protein that inhibits
mineralization by controlling PPi levels. The deletion of
ANKH in mouse results in abnormal mineralization in
articular cartilage and soft tissues.15 To determine whether
TNF promoted vascular calcification by inhibiting ANKH
expression, we examined whether ectopic expression of
ANKH could inhibit TNF-enhanced vascular calcification
in HASMCs by retroviral transduction (Figure 2a). TNF
potently enhanced Pi-induced mineralization in HASMCs
expressing empty vector, but mineralization was significantly
suppressed in HASMCs expressing ANKH (Figure 2b and c).
Consistent with reducing ANKH expression, TNF signifi-
cantly reduced PPi level secretion from both control and
Pi-induced calcified cells (Figure 2d). In addition, ANKH
inhibitor (probenecid, 2mmol/l) decreased and ANKH
overexpression increased PPi secretion (Figure 2e). The effect
of probenecid and TNF on Pi-induced calcification was
equivalent, and TNF failed to further increase calcium
deposition in the presence of probenecid (Figure 2f).
The extracellular matrix protein MGP negatively regulates
mineralization. Because MGP expression was inhibited by
TNF, we examined whether ectopic expression of MGP
attenuated TNF-enhanced mineralization (Supplementary
Figure S1a–c online). Overexpression of MGP significantly
inhibited Pi-induced calcium deposition but was unable to
prevent TNF-enhanced calcium deposition. Thus, TNF may
promote human SMC calcification by inhibiting ANKH
expression, which leads to decreased PPi secretion.
TNF activation of NF-jB suppresses ANKH level and promotes
vascular calcification
Because NF-kB is a major downstream effector, we examined
whether TNF activates NF-kB to inhibit ANKH, thereby
promoting vascular calcification in HASMCs. TNF strongly
induced the expression of NF-kB target genes, including
interleukin 8 (IL-8), IkBa, and monocyte chemoattractant
protein 1 (Figure 3a), all associated with vascular inflamma-
tion. Furthermore, TNF rapidly induced the phosphorylation
and degradation of IkBa in HASMCs; consistently, TNF
stimulated the nuclear translocation of p65, which was
blocked by IkB kinase (IKK) inhibition (IKKbVI, 2mmol/l;
Figure 3b). In accordance, IKK inhibition blocked TNF-
induced decrease in ANKH expression (Figure 3c) and PPi
secretion (Figure 3d) and pro-calcification effects (Figure 3e).
To determine whether TNF-activated NF-kB was suffi-
cient to promote calcification, we overexpressed Flag-tagged
p65 in HASMCs by retroviral transduction (Figure 4a).
Overexpression of p65 significantly enhanced Pi-induced
mineralization (Figure 4b) and induced IL-8 mRNA level
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but repressed ANKH level (Figure 4c). To determine whether
NF-kB was essential for TNF-enhanced mineralization,
we depleted p65 in HASMCs using lentivirus-mediated
expression of short hairpin RNA (shRNA) and confirmed
the knockdown by western blot analysis (Figure 4d). In
contrast to p65 overexpression, p65 knockdown signifi-
cantly reduced TNF-augmented mineralization in Pi-treated
HASMCs (Figure 4e). In accordance, p65 knockdown
inhibited TNF-induced IL-8 expression but rescued TNF-
decreased ANKH level (Figure 4f). ANKH overexpression in
HASMCs prevented p65-augmented calcium deposition
(Figure 4g). Therefore, TNF may activate NF-kB to promote
calcification by downregulating ANKH expression and PPi
secretion.
RNA-destabilizing factor tristetraprolin (TTP) mediates the
effects of TNF on ANKH expression and calcification
Genome-wide analysis of the ANKH promoter predicted the
existence of a transcription-factor NF-kB-binding site (194
to 203 bp), which suggests that TNF might inhibit ANKH
transcription through NF-kB. We subcloned the 0.3-kb
upstream sequence of the ANKH promoter from the
transcription start site (pGL3-ANKH-prom) from human
genomic DNA into the pGL3 luciferase reporter. The basal
luciferase activity was higher for pGL3-ANKH-prom than the
pGL3 control vector in both HASMCs and Human
embryonic kidney 293T (HEK293T) cells (Figure 5a and b).
However, TNF was unable to modulate the basal luciferase
activity of pGL3-ANKH-prom. As a control, TNF potently
Pi
TNF
30
20
10
Ca
lci
um
/p
ro
te
in
 (μ
g/
m
g)
0
30
20
10
Ca
lci
um
/p
ro
te
in
 (μ
g/
m
g)
0
Ctrl 0 2 10 20TNF Pi TNF+Pi
TNF (ng/ml)
* *
*
*
– – +
+– –
+
+
Pi
TNF
+ + +
20 10
+
20
a b
Ca
lci
um
/p
ro
te
in
 (μ
g/
m
g) 45
10
8
6
4
10
5
15
2
0 0
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
1.5
1.0
0.5
0.0
0 H 2 H 8 H 72 H 0 H 2 H 8 H 72 H
R
el
at
iv
e 
m
R
N
A 
le
ve
l
R
el
at
iv
e 
m
R
N
A 
le
ve
l
0 H 2 H 8 H 72 H
*
*
*
*
R
el
at
iv
e 
m
R
N
A 
le
ve
l
35
25
15
5
0Pi mM 1.0 2.0
TNF 10 ng/ml
Vehicle
BMP2 Msx2
ANKHMGPOPN
Pi
Pi+TNF
Pi
Pi+TNF
Pi
Pi+TNF
0 H 2 H 8 H 72 H0 H 2 H 8 H 72 H
R
el
at
iv
e 
m
R
N
A 
le
ve
l
R
el
at
iv
e 
m
R
N
A 
le
ve
l Pi
Pi+TNF
Pi
Pi+TNF
*
*
*
*
*
*
*
*
*
2.3 2.6 3.0
c d e
hgf
Figure 1 |Tumor necrosis factor (TNF) promoted human aortic smooth muscle cell (HASMC) calcification and regulated osteogenic
gene expression. (a) Primary HASMCs were treated with inorganic phosphate (Pi; 3.0mmol/l) and/or TNF (10 ng/ml) for 7 days, and then
calcium deposition was analyzed by Alizarin red staining. (b) HASMCs were treated with Pi (3.0mmol/l) and TNF (0, 2, 10, 20 ng/ml)
for 7 days. (c–e) Reverse transcription (RT)-PCR analysis of the expression of anti-osteogenic genes bone morphogenetic protein 2 (BMP2)
and Msh homeobox 2 (Msx2). (f–h) RT-PCR analysis of the expression of osteogenic genes osteopontin (OPN), matrix Gla protein (MGP),
and ankylosis protein homolog (ANKH). TNF 10 ng/ml, Pi 3.0mmol/l (*Po0.05 compared with Pi, n¼ 3). Ctrl, control.
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stimulated NF-kB luciferase reporter activities in both
HASMCs and HEK293T cells. Therefore, NF-kB may not
regulate ANKH expression at the transcriptional level.
Next, we analyzed the expression of genes regulating
mRNA stability and found that the level of the RNA-
destabilizing factor TTP was increased by TNF, which
depended on NF-kB activation (Figure 5c). Moreover, shRNA
knockdown of TTP (Figure 5d) reversed the TNF-induced
decrease in ANKH expression (Figure 5e) and increase in
calcium deposition (Figure 5f). In accordance, overexpression
of TTP further augmented Pi and PiþTNF-induced
calcification (Figure 5g). Thus, TNF-downregulated ANKH
expression may be due to TTP-mediated ANKH mRNA
degradation.
Inhibition of NF-jB decreases calcium deposition in rat CRF
model and human renal arteries
To further test whether NF-kB activation promoted vascular
calcification in vivo, we used a rat CRF model of vascular
calcification induced by an adenine diet. We blocked NF-kB
in abdominal aortas using the super-repressor form of IkBa,
with serine 32 and 36 replaced by alanines. Abdominal aortas
after 3 weeks of the adenine diet were smeared with Ad-IkBa
or Ad-GFP mixed with matrix gel. At 6 weeks after the diet,
calcium deposition was significantly induced in rat aortas, as
assessed by von Kossa staining (Figure 6a). Ad-GFP did not
affect calcium deposition, but Ad-IkBa significantly inhibited
calcium deposition. ANKH expression was significantly lower
in CRF than control aortas with saline treatment (Figure 6a).
In contrast, Ad-IkBa but not Ad-GFP treatment rescued the
decreased ANKH levels (Figure 6a). To further confirm our
results, we examined ANKH expression in aortas by western
blot analysis and found that Ad-IkBa maintained the
expression of ANKH (Figure 6b). Therefore, NF-kB pro-
moted vascular calcification by inhibiting ANKH expression
in vivo.
Similar to observations in aortas from patients with
CKD,16 serum TNF level was twofold higher in CRF than
normal rats (Figure 6c). In accordance, Pi slightly increased
calcium deposition in human renal artery rings at day 7, and
TNF significantly accelerated the Pi-induced calcification,
which was almost completely reversed by IKK inhibition
(IKKbVI, 2mmol/l; Figure 6d). ANKH expression in aortic
rings was also inhibited by TNF, but Ad-IkBa maintained the
expression of ANKH and decreased TNF-accelerated calcifi-
cation (Supplementary Figure S2 online).
ANKH expression is inversely associated with NF-jB activities
in the human artery wall
To further demonstrate that NF-kB negatively regulated
ANKH expression in vivo, we investigated a possible inverse
relationship between NF-kB and ANKH expression in human
artery walls of patients with CKD or atherosclerosis. Because
the phosphorylation of p65 on Ser536 is associated with NF-
kB activities, we used anti-phospho-NF-kB p65 (Ser536)
antibodies to determine NF-kB activation. In human
atherosclerotic lesions, ANKH protein was weakly detected
in areas strongly stained with phosphorylated p65, where von
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Figure 2 |Decreased secretion of pyrophosphate (PPi) by ankylosis protein homolog (ANKH)-mediated tumor necrosis factor
(TNF)-augmented calcification. Real-time reverse transcription-PCR identified the overexpression of ANKH (a) by retroviral vector in
human aortic smooth muscle cells (HASMCs); EV, empty vector. (b) Calcium content assay and (c) Alizarin red staining of the protective
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Ctrl, control.
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Kossa staining showed clear calcium deposition (Figure 7).
Decreased ANKH protein level was also observed in calcified
aortic walls from CKD patients with increased phosphoryla-
tion of p65 as compared with aortic walls from healthy
donors. Therefore, NF-kB activation in local inflammation in
the human aortic wall may augment calcification by down-
regulating ANKH.
DISCUSSION
Once considered only passive deposition of calcium phos-
phate mineral, vascular calcification is now being recognized
as an actively regulated process that is finely tuned by both
inducers and inhibitors of mineralization. Our study
provides a novel mechanism of pro-inflammatory cytokines
such as TNF exacerbating human SMC calcification by
activating NF-kB. TNF-activated NF-kB suppressed the
expression of the endogenous inhibitor of mineralization
ANKH in vitro and in vivo. We provide a direct link between
chronic inflammation and the osteogenic program attributed
to vascular calcification.
Recent data have implicated the inflammatory cytokines
IL-1, IL-6,17 transforming growth factor-b,18 and TNF13 as
key contributors to the pathogenesis of vascular calcifica-
tion.11 Increased serum level of TNF has been detected in
diabetic, atherosclerotic, and CRF patients. Neutralizing
antibody against TNF greatly abrogated vascular calcification
in an animal model in vivo.6 The mechanisms described so
far involve increased apoptosis and induction of alkaline
phosphatase (ALP) and osteogenic genes such as Runx2 and
Msx2.6,13,19,20 However, how the endogenous inhibitors of
calcification are regulated by inflammatory cytokines is less
defined. Yao et al.21 showed that the procalcific effect of IL-6
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is mediated by increasing the level of heat-shock protein 70 to
antagonize MGP function, an endogenous inhibitor of
mineralization. From a mechanistic viewpoint, our data
provide further evidence that an inflammatory factor
contributes to vascular calcification by regulating the
osteogenic program through both mediators and regulators.
TNF increased the level of the procalcific factor BMP-2 and
decreased that of inhibitors of calcification, ANKH and MGP,
in the presence of the calcification inducer Pi. The
upregulation of BMP-2 by TNF agrees with previous study.14
ANKH was originally identified as a multipass transmem-
brane protein that exports inorganic PPi to the extracellular
space to inhibit hydroxyapatite formation and prevent
calcium deposition in skeletal tissue.15 Mutations in ANKH
result in two distinct calcification disorders: craniometaphy-
seal dysplasia22,23 and familial calcium pyrophosphate
dihydrate deposition disease.24,25 Recent study suggested that
extracellular PPi generation mediated by both ANKH- and
adenosine triphosphate release–dependent mechanisms is a
critical regulator of SMC calcification.26 In our study of
HASMCs, TNF–NF-kB signaling markedly repressed ANKH
expression and PPi secretion and promoted calcification. In
contrast, we and others19 found that TNF–NF-kB signaling
markedly increased ALP activity (data not shown), which can
locally degrade PPi as a necessary step to permit vertebrate
biomineralization. Thus, TNF-decreased PPi level may result
from depressed ANKH expression and enhanced ALP
activity. In addition, the restoration of ANKH expression
greatly rescued PPi secretion and TNF-induced calcification,
which may be a way to counteract TNF-augmented
calcification regardless of ALP activity. Furthermore, TNF
could not further increase Pi-induced calcification in the
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presence of ANKH inhibition, which indicates that reducing
PPi secretion is a major mechanism of TNF-augmented
calcification. We further verified the inverse association of
NF-kB activation and ANKH expression in a CRF animal
model with high serum level of TNF. Collectively, these data
strongly indicate an important TNF–NF-kB–ANKH-PPi axis
attributed to vascular calcification. Because aortas from
patients with CKD showed enhanced TNF level16 and our
CRF rats showed a twofold increase in serum TNF level, and
together with the presented results showed a role for TNF
in vascular calcification, further research with TNF blockers
on treating or preventing vascular calcification in vivo was
prompted.
We found decreased MGP expression with TNF treatment.
The depletion of MGP was previously found to promote
vascular calcification in vivo.27 However, MGP overexpres-
sion failed to prevent the procalcific effect of TNF in our
in vitro assay of HASMCs, possibly because overexpressed
MGP has full function only after it is posttranslationally
modified by a vitamin K–dependent g-glutamyl carboxylase
into g-carboxyglutamic acid (Gla) residues.28 However,
g-glutamyl carboxylase is not expressed in SMCs29 and is
absent in culture media. In addition, the ectopic expression
of MGP may not be strong enough to antagonize TNF-
promoted calcification. Nevertheless, our results suggest that
chronic inflammation may promote vascular calcification by
inhibiting the effect of mineralization inhibitor ANKH.
TNF has been found to downregulate the expression of
COL1A2, FGF10, and MyoD through mechanisms including
transcriptional repression,30 physical interfering interac-
tion,31 and posttranscriptional downregulation.32 Although
we predicted potential NF-kB-binding sites located within
the promoter region of ANKH, we were unable to identify
the direct transcriptional repression of ANKH by NF-kB
using luciferase reporter assays. Instead, consistent with
Carballo et al.33 and King et al.,34 we found that TNF
stimulated the expression of the RNA-destabilizing factor
TTP. Indeed, analysis of ANKH mRNA level revealed at least
15 AU-rich elements (AUUUA) within the 30 UTR, which
allows for TTP binding and promotes ANKH mRNA
degradation. With knockdown of TTP by shRNA, the TNF-
induced decrease in ANKH expression and increase in
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Figure 5 |Nuclear factor-jB (NF-jB)-dependent expression of tristetraprolin (TTP) mediated the effects of tumor necrosis factor
(TNF) on ankylosis protein homolog (ANKH) expression and calcification. ANKH-promoter activity assay with pGL3 luciferase reporter
in (a) human aortic smooth muscle cells (HASMCs) and (b) human embryonic kidney 293T (HEK293T) cells. (c) IkB kinase (IKK) inhibitor was
added to block NF-kB signal; reverse transcription-PCR analysis of TTP mRNA level. After transfection of scramble or TTP shRNA (short
hairpin RNA; pSingle-tTS-TTP-shRNA) for 24 h, RT-PCR analysis of mRNA level of (d) TTP and (e) ANKH with or without TNF (10 ng/ml) was
performed. (f) Calcium content assay: after transfection of scramble or TTP shRNA for 24 h, cells were treated with inorganic phosphate (Pi)
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calcium deposition were reversed, and overexpression of TTP
promoted calcification. Therefore, TTP mediates the effects
of TNF on ANKH expression and calcification.
Our study provides direct evidence that TNF-mediated
NF-kB activation aggravates human vascular calcification via
TTP-dependent repression of ANKH, the endogenous
mineralization inhibitor. These data may shed light on
understanding the complexity of vascular calcification during
CRF, diabetes, and atherosclerosis.
MATERIALS AND METHODS
Materials
Sodium phosphate (Na2HPO4 and NaH2PO4) was from Fisher
Scientific (Fair Lawn, NJ); minimum essential medium-a, Dulbecco’s
modified Eagle’s medium, fetal bovine serum, and penicillin-
streptomycin were from GIBCO (Grand Island, NE). TRIzol was
from Invitrogen (Carlsbad, CA); the luciferase assay system was
from Promega (Madison, WI); Alizarin red stain, cetylpyridinium
chloride, and adenine were from Amresco (Cochran Solon, OH);
and IKK inhibitor (IKKbVI) and primers for PCR were from Sigma-
Aldrich (St Louis, MO). Antibodies for ANKH, phosphor-p65
(s536), IkBa, b-actin, and GAPDH were from Santa Cruz
Biotechnology (Santa Cruz, CA); p65 was from Millipore (Billerica,
MA); phosphor-IkBa was from Cell Signaling (Danvers, MA), and
a-tubulin was from Sigma-Aldrich.
Patients
We excised 2- to 3-mm circumferential segments of renal arteries
from healthy donors during renal transplantation. Arteries of uremic
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Figure 6 | Inhibitor of kappa B protein-a (IjBa) increased ankylosis protein homolog (ANKH) expression and decreased calcium
deposition in in vivo and ex vivo models. (a) In the rat chronic renal failure (CRF) model, Ad-IkBa or Ad-GFP were mixed with matrix
gel and smeared around the abdominal aorta. Calcium deposition was analyzed by von Kossa staining. Adenine, adenine diet at 6 weeks.
ANKH and p-p65 levels were detected by immunohistochemical staining; the figure shows one representative image from six rats per
group ( 400). (b) Western blot analysis of protein levels of ANKH and IkBa in abdominal aortas. (c) Serum tumor necrosis factor (TNF)
level in CRF rats (n¼ 6 rats per group, *Po0.05). (d) Calcium content in human renal artery tissue cultured in Dulbecco’s modified
Eagle’s medium with Pi (3.0mmol/l) and/or TNF (10 ng/ml) for 2 weeks (n¼ 4 per group, *Po0.05). Ctrl, control; IKK, IkB kinase.
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patients were from clinical discards of the slim abdominal aorta strip
excised for aortic inosculation. Atherosclerotic tissue samples were
obtained from patients by directional atherectomy according to
protocols approved by the Medical Ethical Committee of the Health
Science Center of Peking University, which comply with the
principles outlined in the Declaration of Helsinki Principles.35 All
patients gave their informed consent for use of the tissue biopsy
before surgery. Institutional review board approval was granted to
our study.
Animal model
We used the animal vascular calcification model with male Wistar
rats (n¼ 32, VitalRiver Laboratories, Beijing, China). Eight-week-
old rats were pair-fed with standard chow containing 1.2% calcium
and 0.6% phosphorus for the control group or 0.75% adenine
(Sigma-Aldrich), 1.2% calcium, and 1% phosphorus for the CRF
group for 6 weeks as described previously8,36 (serum biochemical
parameters are in Supplementary Table S1 online). After 3 weeks,
rats were anesthetized with pentobarbital sodium by intraperitoneal
injection (40mg/kg) and then surgery was performed. The left renal
artery was the center marker, and B2.0 cm of abdominal aorta was
exposed. Adenovirus (Ad)-IkBa or Ad-GFP (5 109 plaque forming
units) was mixed with 200 ml matrix gel (Sigma, St Louis, MO) and
smeared around the exposed abdominal aorta. The abdominal
aortas were excised for western blot analysis and immunostaining.
All surgical procedures and postoperative care were performed in
accordance with guidelines of Peking University Animal Care and
Use Committee.
Cell and vascular tissue culture
HASMCs were obtained from Invitrogen and grown in a humidified
5% CO2 incubator at 37 1C in minimum essential medium-a
supplemented with 15% fetal bovine serum and 1% penicillin-
streptomycin. The HASMCs were infected with retroviral vector and
lentiviral vector as described,37 and then cultured with calcifying
medium with 3.0mmol/l (Pi). HEK293T cells were obtained from
the American Type Culture Collection.
The main branch of the human renal aorta was isolated during
nephrectomy in patients with renal cancer without diabetic or renal
complications, and adventitia was removed, and then maintained in
a humidified 5% CO2 incubator at 37 1C in Dulbecco’s modified
Eagle’s medium containing 1% penicillin-streptomycin. Ad-IkBa
(108 p.f.u./ml) was used to infect the vascular tissue on the first day
of culture, and then vascular tissue was moved to calcification
medium with or without TNF (10 ng/ml) on the second day. After
2 weeks of culture, von Kossa staining, calcium deposition analysis,
and immunohistochemical analysis were performed to analyze
calcification and ANKH and phospho-p65 levels.
Histological observation
Specimens of calcifying arteries and atherosclerotic plaques were
fixed in 4% formalin, embedded in paraffin, and examined with
IHC or immunofluorescence. The corresponding normal IgG was a
negative control. Semiquantitative analysis of the staining involved
Image-Pro Plus (Media Cybernetics, Bethesda, MD).
Quantification of calcium deposition
To assess the mineralization in in vitro experiments, cells were
induced for 7 days and stained with 2% Alizarin red, and then
destained with 10% cetylpyridinium chloride for 30min at room
temperature; the concentration was determined by measuring
absorbance at 562 nm. For ex vivo (human) and in vivo (rat)
measurement, vascular tissues from nephrectomy and the animal
model were dissolved in HNO3, and the calcium content was
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Figure 7 |Calcium deposition, ankylosis protein homolog (ANKH) expression, and phosphor-p65 level in the human aortic wall.
(a–c) Atherosclerotic lesion samples were obtained from patients by directional atherectomy; (d–f) aortic wall samples were obtained
from patients with chronic kidney disease (CKD); (g–i) aortic wall samples were obtained from healthy donors during renal transplantation.
(a, d, g) von Kossa staining of calcium deposition. (b, e, h) Immunohistochemical staining of ANKH protein level. (c, f, i) Immunofluorescence
staining (green) or immunohistochemical staining of p-p65 (s536) level. M¼ tunica media, A¼ adventitia.
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measured as we described previously,38 or fixed and sectioned, and
calcium deposition was detected by von Kossa staining.
Vector construction
The 0.3-kb promoter for the coding sequence of human ANKH gene
was synthesized by Sunbiotech (Beijing, China) and then subcloned
into pGL3 luciferase reporter vector (Promega). Full-length ANKH
mRNA with an additional kozak sequence from the human genome
was amplified by reverse transcription-PCR (primers: 50ACCGGTG
CCACCATGGTGAAATTCCCGGCGCT and 50GAATTCTTATTCAT
TCTCCTCTCTCATT) and then sub-cloned into a pQNCX2 retro-
viral vector. For viral infection, HASMCs were plated overnight
and then infected with retroviruses in the presence of polybrene
(6mg/ml, Sigma-Aldrich) for 6 h. The p65 shRNA with the target
sequence 50-GGATTGAGGAGAAACGTAA-30 was subcloned into
the pLKO Lentiviral vector from Addgene (Cambridge, MA), and
retrovirus packaging was as described.37 The plasmid pSingle-
tTS-TTP-shRNA was kindly provided by Dr Wen-Gong Wang
(Peking University). The Ad-IkBa virus was kindly provided by
Dr Nan-Ping Wang (Peking University).
Transfection and luciferase activity assay
At 24 h after plating, cells were co-transfected using Lipofectamine
2000 (Invitrogen) with pGL3-ANKH-prom and the transfection
control b-gal expression vector. Thereafter, 6 h later, transfection
media was replaced with Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum. On the following day, cells were
treated with vehicle or TNF. Cell lysates were harvested 48 h after
transfection. Luciferase activity of cell lysates was assayed using the
Dual Luciferase Reporter kit (Promega).
PPi assay
Medium PPi levels were measured using the PPiLight Pyrophos-
phate Detection Kit (Lonza, Rockland, MA) according to the
manufacturer’s instruction. Briefly, add 20ml of PPiLight detection
reagent to 40 ml of medium sample, and after 10min incubation
at room temperature measure the initial steady-state biolumines-
cence with the luminometer, as basal level. In another tube, add
20 ml of PPiLight converting reagent to 40 ml of medium sample
and incubate at room temperature for 30min, then add 20 ml
of PPiLight detection reagent and incubate for 30min; finally,
read luminescence and subtract the value from the original
ATP-dependent bioluminescence value to yield PPi-dependent
bioluminescence.
Real-time reverse transcription-PCR
RNA was isolated using TRIzol regent according to the manufac-
turer’s directions and quantified by UV spectrophotometry; then the
extracted mRNA was reverse transcribed with 4 mg denatured RNA
and 50 ng random hexamers (Invitrogen) in a 20-ml total volume
containing 200 U Super Script III reverse transcriptase. Real-time
PCR involved the Single-Colour Real-Time PCR detection system
(Bio-Rad, Hercules, CA) with 1 ml cDNA and 1 SYBR Green dye.
The housekeeping gene 18S rRNA was used for internal normal-
ization. Oligonucleotides synthesized by Sigma-Aldrich are listed in
Supplementary Table S2 online.
Statistics
Data are reported as mean±s.e.m. Unpaired Student’s t-test was
used for analysis of two groups and one-way or two-way ANOVA for
analysis of three or more groups, and then Bonferroni’s multiple
comparison tests as applicable. Po0.05 was considered significant.
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